A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/17878176

Download in:

View as

Triples

General Info

PMID
17878176